Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2025 Filed Feb 13, 2025 21:05 UTC |
Skycrest Holdings, LLCFormer 10% Owner
|
PurchaseCommon Stock | 3,000 | $3.22 | $9,660.00 |
DisclosureSEC source: 0001829126-25-000937 · ownership.xml · nonDerivative · entry 1 Skycrest Holdings, LLC · CIK 0001952164 · Former 10% Owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,687 Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 21:40 UTC |
Skycrest Holdings, LLCFormer 10% Owner
|
PurchaseCommon Stock | 2,000 | $3.06 | $6,120.00 |
DisclosureSEC source: 0001829126-25-000728 · ownership.xml · nonDerivative · entry 3 Skycrest Holdings, LLC · CIK 0001952164 · Former 10% Owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 307,687 Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 21:40 UTC |
Skycrest Holdings, LLCFormer 10% Owner
|
PurchaseCommon Stock | 3,000 | $3.10 | $9,300.00 |
DisclosureSEC source: 0001829126-25-000728 · ownership.xml · nonDerivative · entry 2 Skycrest Holdings, LLC · CIK 0001952164 · Former 10% Owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305,687 Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:40 UTC |
Skycrest Holdings, LLCFormer 10% Owner
|
PurchaseCommon Stock | 520 | $2.65 | $1,378.00 |
DisclosureSEC source: 0001829126-25-000728 · ownership.xml · nonDerivative · entry 1 Skycrest Holdings, LLC · CIK 0001952164 · Former 10% Owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302,687 Read SEC document |
| December 30, 2024 Filed Dec 30, 2024 23:08 UTC |
BOTHWELL IAN TDirector · Interim CEO & CFO · 10% owner
|
GiftSeries C Preferred | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001829126-24-008636 · ownership.xml · nonDerivative · entry 1 BOTHWELL IAN T · CIK 0001207638 · Director · Interim CEO & CFO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50 Read SEC document |
| December 30, 2024 Filed Dec 30, 2024 23:12 UTC |
Skycrest Holdings, LLC10% owner
|
GiftSeries C Preferred | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001829126-24-008637 · ownership.xml · nonDerivative · entry 1 Skycrest Holdings, LLC · CIK 0001952164 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 26, 2024 Filed Dec 30, 2024 23:12 UTC |
Skycrest Holdings, LLC10% owner
|
GiftWarrant to purchase Common Stock · Derivative | 350,000 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001829126-24-008637 · ownership.xml · derivative · entry 2 Skycrest Holdings, LLC · CIK 0001952164 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 350,000 shares Expires 2034-07-11 F1 · kind: The warrants vest in equal monthly installments over a period of eighteen (18) months from the grant date. F1 · derivative.exercise_date: The warrants vest in equal monthly installments over a period of eighteen (18) months from the grant date. Read SEC document |
| December 11, 2024 Filed Dec 12, 2024 22:50 UTC |
Skycrest Holdings, LLC10% owner
|
PurchaseCommon Stock | 266 | $3.02 | $803.32 |
DisclosureSEC source: 0001829126-24-008285 · ownership.xml · nonDerivative · entry 1 Skycrest Holdings, LLC · CIK 0001952164 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302,167 Read SEC document |
| December 03, 2024 Filed Dec 20, 2024 21:05 UTC |
Skycrest Holdings, LLC10% owner
|
GiftWarrants to purchase Common Stock · Derivative | 750,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001829126-24-008455 · ownership.xml · derivative · entry 1 Skycrest Holdings, LLC · CIK 0001952164 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 750,000 shares Expires 2032-07-13 Read SEC document |
| November 22, 2024 Filed Nov 22, 2024 22:18 UTC |
Skycrest Holdings, LLC10% owner
|
PurchaseCommon Stock | 10,508 | $4.00 | $42,032.00 |
DisclosureSEC source: 0001829126-24-007784 · ownership.xml · nonDerivative · entry 2 Skycrest Holdings, LLC · CIK 0001952164 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 301,901 Read SEC document |
| November 20, 2024 Filed Nov 20, 2024 23:36 UTC |
Skycrest Holdings, LLC10% owner
|
PurchaseCommon Stock | 7,289 | $2.75 | $20,044.75 |
DisclosureSEC source: 0001829126-24-007713 · ownership.xml · nonDerivative · entry 3 Skycrest Holdings, LLC · CIK 0001952164 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,893 Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 22:18 UTC |
Skycrest Holdings, LLC10% owner
|
PurchaseCommon Stock | 500 | $2.95 | $1,475.00 |
DisclosureSEC source: 0001829126-24-007784 · ownership.xml · nonDerivative · entry 1 Skycrest Holdings, LLC · CIK 0001952164 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,393 Read SEC document |
| November 19, 2024 Filed Nov 20, 2024 23:36 UTC |
Skycrest Holdings, LLC10% owner
|
PurchaseCommon Stock | 5,000 | $2.65 | $13,250.00 |
DisclosureSEC source: 0001829126-24-007713 · ownership.xml · nonDerivative · entry 2 Skycrest Holdings, LLC · CIK 0001952164 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,604 Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 23:36 UTC |
Skycrest Holdings, LLC10% owner
|
PurchaseCommon Stock | 10,000 | $2.59 | $25,900.00 |
DisclosureSEC source: 0001829126-24-007713 · ownership.xml · nonDerivative · entry 1 Skycrest Holdings, LLC · CIK 0001952164 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,604 Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 00:52 UTC |
Skycrest Holdings, LLC10% owner
|
PurchaseCommon Stock | 9,000 | $2.20 | $19,800.00 |
DisclosureSEC source: 0001829126-24-006080 · ownership.xml · nonDerivative · entry 2 Skycrest Holdings, LLC · CIK 0001952164 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,604 Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 00:52 UTC |
Skycrest Holdings, LLC10% owner
|
PurchaseCommon Stock | 1,000 | $2.20 | $2,200.00 |
DisclosureSEC source: 0001829126-24-006080 · ownership.xml · nonDerivative · entry 1 Skycrest Holdings, LLC · CIK 0001952164 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,604 Read SEC document |
| July 11, 2024 Filed Jul 15, 2024 23:00 UTC |
Grey Wendy10% owner
Greyt Ventures, LLC10% owner
|
GrantWarrant to purchase Common Stock · Derivative | 350,000 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001829126-24-004812 · ownership.xml · derivative · entry 1 Grey Wendy · CIK 0001946695 · 10% owner Greyt Ventures, LLC · CIK 0001946700 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2034-07-11 F1 · kind: The warrants vest in equal monthly instalments over a period of eighteen (18) months from the grant date. F1 · derivative.exercise_date: The warrants vest in equal monthly instalments over a period of eighteen (18) months from the grant date. F2 · ownership.nature: Securities issued to Greyt Ventures, LLC by Issuer. Greyt Ventures, LLC is owned by a trust for which Ms. Grey is trustee. Read SEC document |
| July 11, 2024 Filed Jul 15, 2024 17:20 UTC |
Bretz Charles LutherDirector
|
GrantStock Options · Derivative | 50,000 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001829126-24-004803 · ownership.xml · derivative · entry 1 Bretz Charles Luther · CIK 0001947541 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-07-11 F1 · kind: Represents the grant of stock options under the issuer's 2021 Equity Incentive Plan (the "Plan"). The options vest in equal monthly installments over a period of eighteen (18) months from the grant date and are subject to the terms of the Plan. F1 · derivative.exercise_date: Represents the grant of stock options under the issuer's 2021 Equity Incentive Plan (the "Plan"). The options vest in equal monthly installments over a period of eighteen (18) months from the grant date and are subject to the terms of the Plan. Read SEC document |
| July 11, 2024 Filed Jul 15, 2024 21:20 UTC |
BOTHWELL IAN TDirector · Interim CEO & CFO · 10% owner
|
GrantStock Options · Derivative | 125,000 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001829126-24-004802 · ownership.xml · derivative · entry 1 BOTHWELL IAN T · CIK 0001207638 · Director · Interim CEO & CFO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2034-07-11 F1 · kind: Represents the grant of stock options under the issuer's 2021 Equity Incentive Plan (the "Plan"). The options vest in equal monthly installments over a period of eighteen (18) months from the grant date and are subject to the terms of the Plan. F1 · derivative.exercise_date: Represents the grant of stock options under the issuer's 2021 Equity Incentive Plan (the "Plan"). The options vest in equal monthly installments over a period of eighteen (18) months from the grant date and are subject to the terms of the Plan. Read SEC document |
| July 11, 2024 Filed Jul 15, 2024 17:20 UTC |
GLAUSER STEVEN JERRYDirector
|
GrantStock Options · Derivative | 125,000 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001829126-24-004804 · ownership.xml · derivative · entry 1 GLAUSER STEVEN JERRY · CIK 0001385272 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2034-07-11 F1 · kind: Represents the grant of stock options under the issuer's 2021 Equity Incentive Plan (the "Plan"). The options vest in equal monthly installments over a period of eighteen (18) months from the grant date and are subject to the terms of the Plan. F1 · derivative.exercise_date: Represents the grant of stock options under the issuer's 2021 Equity Incentive Plan (the "Plan"). The options vest in equal monthly installments over a period of eighteen (18) months from the grant date and are subject to the terms of the Plan. Read SEC document |
| July 11, 2024 Filed Jul 15, 2024 21:22 UTC |
Stearn Leathem SDirector
|
GrantStock Options · Derivative | 125,000 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001829126-24-004807 · ownership.xml · derivative · entry 1 Stearn Leathem S · CIK 0001950011 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2034-07-11 F1 · kind: Represents the grant of stock options under the issuer's 2021 Equity Incentive Plan (the "Plan"). The options vest in equal monthly installments over a period of eighteen (18) months from the grant date and are subject to the terms of the Plan. F1 · derivative.exercise_date: Represents the grant of stock options under the issuer's 2021 Equity Incentive Plan (the "Plan"). The options vest in equal monthly installments over a period of eighteen (18) months from the grant date and are subject to the terms of the Plan. Read SEC document |
| July 11, 2024 Filed Jul 15, 2024 21:21 UTC |
Skycrest Holdings, LLC10% owner
|
GrantWarrant to purchase Common Stock · Derivative | 350,000 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001829126-24-004806 · ownership.xml · derivative · entry 1 Skycrest Holdings, LLC · CIK 0001952164 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2034-07-11 F1 · kind: The warrants vest in equal monthly installments over a period of eighteen (18) months from the grant date. F1 · derivative.exercise_date: The warrants vest in equal monthly installments over a period of eighteen (18) months from the grant date. Read SEC document |
| July 11, 2024 Filed Jul 15, 2024 21:21 UTC |
Shapiro George CraigDirector · Chief Medical Officer
|
GrantStock Options · Derivative | 125,000 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001829126-24-004805 · ownership.xml · derivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2034-07-11 F1 · kind: Represents the grant of stock options under the issuer's 2021 Equity Incentive Plan (the "Plan"). The options vest in equal monthly installments over a period of eighteen (18) months from the grant date and are subject to the terms of the Plan. F1 · derivative.exercise_date: Represents the grant of stock options under the issuer's 2021 Equity Incentive Plan (the "Plan"). The options vest in equal monthly installments over a period of eighteen (18) months from the grant date and are subject to the terms of the Plan. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 16:10 UTC |
Bretz Charles LutherDirector
|
GrantStock Options · Derivative | 5,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001829126-24-002157 · ownership.xml · derivative · entry 1 Bretz Charles Luther · CIK 0001947541 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-04-01 F1 · kind: Represents the grant of stock options under the 2021 Plan. The options vested as to 2,500 shares as of the grant date and will vest as to the remaining 2,500 shares on September 23, 2024. F1 · derivative.exercise_date: Represents the grant of stock options under the 2021 Plan. The options vested as to 2,500 shares as of the grant date and will vest as to the remaining 2,500 shares on September 23, 2024. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 16:10 UTC |
GLAUSER STEVEN JERRYDirector
|
GrantStock Options · Derivative | 5,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001829126-24-002158 · ownership.xml · derivative · entry 2 GLAUSER STEVEN JERRY · CIK 0001385272 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-04-01 F2 · kind: Represents the grant of stock options under the 2021 Plan. The options vested as to 2,500 shares as of the grant date and will vest as to the remaining 2,500 shares on September 23, 2024. F2 · derivative.exercise_date: Represents the grant of stock options under the 2021 Plan. The options vested as to 2,500 shares as of the grant date and will vest as to the remaining 2,500 shares on September 23, 2024. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 16:10 UTC |
GLAUSER STEVEN JERRYDirector
|
GrantCommon Stock, $.001 par value | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001829126-24-002158 · ownership.xml · nonDerivative · entry 1 GLAUSER STEVEN JERRY · CIK 0001385272 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 258,334 F1 · kind: Represents an award of shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The award vested in full as of the date of grant. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:11 UTC |
Singh Gurvinder PalDirector
|
GrantStock Options · Derivative | 5,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001829126-24-002160 · ownership.xml · derivative · entry 1 Singh Gurvinder Pal · CIK 0001944625 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-04-01 F1 · kind: Represents the grant of stock options under the 2021 Plan. The options vested as to 2,500 shares as of the grant date and will vest as to the remaining 2,500 shares on September 23, 2024. F1 · derivative.exercise_date: Represents the grant of stock options under the 2021 Plan. The options vested as to 2,500 shares as of the grant date and will vest as to the remaining 2,500 shares on September 23, 2024. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:11 UTC |
Stearn Leathem SDirector
|
GrantStock Options · Derivative | 5,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001829126-24-002159 · ownership.xml · derivative · entry 2 Stearn Leathem S · CIK 0001950011 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-04-01 F3 · kind: Represents the grant of stock options under the 2021 Plan. The options vested as to 2,500 shares as of the grant date and will vest as to the remaining 2,500 shares on September 23, 2024. F3 · derivative.exercise_date: Represents the grant of stock options under the 2021 Plan. The options vested as to 2,500 shares as of the grant date and will vest as to the remaining 2,500 shares on September 23, 2024. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:11 UTC |
Stearn Leathem SDirector
|
GrantCommon Stock, $.001 par value | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001829126-24-002159 · ownership.xml · nonDerivative · entry 1 Stearn Leathem S · CIK 0001950011 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Stearn Enterprises, LLC Disclosed balance after: 125,000 F1 · kind: Represents an award of shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The award vested in full as of the date of grant. F2 · ownership.nature: The Reporting Person is the sole beneficial owner of Stearn Enterprises, LLC. Read SEC document |
| December 19, 2023 Filed Dec 20, 2023 21:05 UTC |
Leider Harry L.Director · Chief Executive Officer
|
SaleCommon Stock | 5,248 | $1.32 | $6,901.12 |
DisclosureSEC source: 0001829126-23-008139 · ownership.xml · nonDerivative · entry 1 Leider Harry L. · CIK 0001888273 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · ownership.nature: The shares disposed of were held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee. Read SEC document |
| July 07, 2023 Filed Jul 11, 2023 20:15 UTC |
Skycrest Holdings, LLC10% owner
|
PurchaseCommon Stock | 320,710 | $0.01 | $2,886.39 |
DisclosureSEC source: 0001829126-23-004623 · ownership.xml · nonDerivative · entry 1 Skycrest Holdings, LLC · CIK 0001952164 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,720,710 Read SEC document |
| June 29, 2023 Filed Jun 30, 2023 20:05 UTC |
Leider Harry L.Director · Chief Executive Officer
|
PurchaseCommon Stock | 500,000 | $0.01 | $5,000.00 |
DisclosureSEC source: 0001829126-23-004521 · ownership.xml · nonDerivative · entry 2 Leider Harry L. · CIK 0001888273 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,049,450 F1 · ownership.nature: The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee. Read SEC document |
| June 29, 2023 Filed Jun 30, 2023 20:05 UTC |
Skycrest Holdings, LLC10% owner
|
PurchaseCommon Stock | 200,000 | $0.01 | $1,800.00 |
DisclosureSEC source: 0001829126-23-004522 · ownership.xml · nonDerivative · entry 2 Skycrest Holdings, LLC · CIK 0001952164 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,400,000 Read SEC document |
| June 29, 2023 Filed Dec 21, 2023 21:01 UTC Amendment |
Leider Harry L.Director · Chief Executive Officer
|
PurchaseCommon Stock | 500,000 | $0.01 | $5,000.00 |
DisclosureSEC source: 0001829126-23-008158 · ownership.xml · nonDerivative · entry 2 Leider Harry L. · CIK 0001888273 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,049,450 F1 · ownership.nature: The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee. The purpose of this Amendment is to correct the purchase price for the shares purchased on June 28, 2023. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:05 UTC |
Leider Harry L.Director · Chief Executive Officer
|
PurchaseCommon Stock | 549,450 | $0.10 | $54,395.55 |
DisclosureSEC source: 0001829126-23-004521 · ownership.xml · nonDerivative · entry 1 Leider Harry L. · CIK 0001888273 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 549,450 F1 · ownership.nature: The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:05 UTC |
Skycrest Holdings, LLC10% owner
|
PurchaseCommon Stock | 400,000 | $0.01 | $3,600.00 |
DisclosureSEC source: 0001829126-23-004522 · ownership.xml · nonDerivative · entry 1 Skycrest Holdings, LLC · CIK 0001952164 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,200,000 Read SEC document |
| June 28, 2023 Filed Dec 21, 2023 21:01 UTC Amendment |
Leider Harry L.Director · Chief Executive Officer
|
PurchaseCommon Stock | 549,450 | $0.01 | $5,439.56 |
DisclosureSEC source: 0001829126-23-008158 · ownership.xml · nonDerivative · entry 1 Leider Harry L. · CIK 0001888273 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 549,450 F1 · ownership.nature: The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee. The purpose of this Amendment is to correct the purchase price for the shares purchased on June 28, 2023. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 20:12 UTC |
Skycrest Holdings, LLC10% owner
|
PurchaseCommon Stock | 800,000 | $0.01 | $7,200.00 |
DisclosureSEC source: 0001829126-23-004454 · ownership.xml · nonDerivative · entry 1 Skycrest Holdings, LLC · CIK 0001952164 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,800,000 Read SEC document |
| October 31, 2022 Filed Nov 1, 2022 21:48 UTC |
Sinnreich Matthew PhillipDirector · President and Acting CEO
|
OtherCommon Stock, $0.001 par value | 6,979 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001829126-22-018546 · ownership.xml · nonDerivative · entry 1 Sinnreich Matthew Phillip · CIK 0001939708 · Director · President and Acting CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · kind: On October 31, 2022, the Reporting Person relinquished his ownership interest in Retrograde Investments, LLC, which held the shares of common stock reported hereunder. As a result, the Reporting Person no longer exercises any voting or and dispositive power over such shares. F1 · price: On October 31, 2022, the Reporting Person relinquished his ownership interest in Retrograde Investments, LLC, which held the shares of common stock reported hereunder. As a result, the Reporting Person no longer exercises any voting or and dispositive power over such shares. F1 · ownership.nature: On October 31, 2022, the Reporting Person relinquished his ownership interest in Retrograde Investments, LLC, which held the shares of common stock reported hereunder. As a result, the Reporting Person no longer exercises any voting or and dispositive power over such shares. Read SEC document |
| October 31, 2022 Filed Nov 3, 2022 17:01 UTC Amendment |
Sinnreich Matthew PhillipDirector · President and Acting CEO
|
OtherCommon Stock, $0.001 par value | 6,976,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001829126-22-018721 · ownership.xml · nonDerivative · entry 1 Sinnreich Matthew Phillip · CIK 0001939708 · Director · President and Acting CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · kind: On October 31, 2022, the Reporting Person relinquished his ownership interest in Retrograde Investments, LLC, which held the shares of common stock reported hereunder. As a result, the Reporting Person no longer exercises any voting or and dispositive power over such shares. F1 · price: On October 31, 2022, the Reporting Person relinquished his ownership interest in Retrograde Investments, LLC, which held the shares of common stock reported hereunder. As a result, the Reporting Person no longer exercises any voting or and dispositive power over such shares. F1 · ownership.nature: On October 31, 2022, the Reporting Person relinquished his ownership interest in Retrograde Investments, LLC, which held the shares of common stock reported hereunder. As a result, the Reporting Person no longer exercises any voting or and dispositive power over such shares. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 06:00 UTC |
Sinnreich Matthew PhillipDirector · President and Acting CEO
|
SaleCommon Stock, $0.001 par value | 20,000 | $0.04 | $800.00 |
DisclosureSEC source: 0001829126-22-017985 · ownership.xml · nonDerivative · entry 1 Sinnreich Matthew Phillip · CIK 0001939708 · Director · President and Acting CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 6,976,000 F1 · ownership.nature: Represents shares of common stock held by Retrograde Investments, LLC, in which entity the Reporting Person is a minority holder and over which the Reporting Person has shared voting and dispositive power. Read SEC document |
| August 19, 2022 Filed Aug 24, 2022 20:53 UTC |
BOTHWELL IAN TDirector · Chief Financial Officer · 10% owner
|
GrantWarrant to purchase Common Stock · Derivative | 30,000,000 | Not disclosed Strike: $0.02 | Not disclosed |
DisclosureSEC source: 0001829126-22-016138 · ownership.xml · derivative · entry 1 BOTHWELL IAN T · CIK 0001207638 · Director · Chief Financial Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000,000 Underlying: Common Stock · 30,000,000 shares Expires 2032-08-19 F1 · kind: The Warrants were issued to the Reporting Person in consideration of the Reporting Person having agreed with the Issuer to waive payment of certain accrued but unpaid compensation due him as of July 31, 2022 pursuant to his employment agreement with the Issuer. F1 · price: The Warrants were issued to the Reporting Person in consideration of the Reporting Person having agreed with the Issuer to waive payment of certain accrued but unpaid compensation due him as of July 31, 2022 pursuant to his employment agreement with the Issuer. Read SEC document |
| August 19, 2022 Filed Aug 24, 2022 20:54 UTC |
Shapiro George CraigDirector · Chief Medical Officer
|
GrantWarrant to Purchase Common Stock · Derivative | 3,150,000 | Not disclosed Strike: $0.02 | Not disclosed |
DisclosureSEC source: 0001829126-22-016140 · ownership.xml · derivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,150,000 Underlying: Common Stock · 3,150,000 shares Expires 2032-08-19 F1 · kind: The Warrants were issued to the Reporting Person in consideration of the Reporting Person having agreed with the Issuer to waive payment of certain accrued but unpaid consulting fees due him as of July 31, 2022 and to terminate the consulting arrangement with the Issuer. F1 · price: The Warrants were issued to the Reporting Person in consideration of the Reporting Person having agreed with the Issuer to waive payment of certain accrued but unpaid consulting fees due him as of July 31, 2022 and to terminate the consulting arrangement with the Issuer. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 21:51 UTC |
MITRANI MARIA INESChief Science Officer
|
OtherCommon Stock | 15,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-21-005204 · ownership.xml · nonDerivative · entry 2 MITRANI MARIA INES · CIK 0001690319 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,707,890 F1 · kind: The shares of common stock of Organicell Regenerative Medicine, Inc., a Nevada corporation (the "Company") were disposed of and acquired, respectively, pursuant to an Exchange Agreement dated October 29, 2021 (the "Agreement"), whereby the Reporting Person exchanged shares of common stock of the Company previously issued under the Organicell Regenerative Medicine, Inc. Management and Consultants Performance Stock Plan for shares of common stock of the Company in the Organicell Regenerative Medicine, Inc. 2021 Equity Incentive Plan. The newly issued shares shall vest on December 31, 2023. F2 · price: Received in exchange for the Company's common stock on a 1:1 basis. This exchange was completed in connection with the Agreement. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 21:51 UTC |
MITRANI MARIA INESChief Science Officer
|
OtherCommon Stock | 15,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-21-005204 · ownership.xml · nonDerivative · entry 1 MITRANI MARIA INES · CIK 0001690319 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,707,890 F1 · kind: The shares of common stock of Organicell Regenerative Medicine, Inc., a Nevada corporation (the "Company") were disposed of and acquired, respectively, pursuant to an Exchange Agreement dated October 29, 2021 (the "Agreement"), whereby the Reporting Person exchanged shares of common stock of the Company previously issued under the Organicell Regenerative Medicine, Inc. Management and Consultants Performance Stock Plan for shares of common stock of the Company in the Organicell Regenerative Medicine, Inc. 2021 Equity Incentive Plan. The newly issued shares shall vest on December 31, 2023. F2 · price: Received in exchange for the Company's common stock on a 1:1 basis. This exchange was completed in connection with the Agreement. Read SEC document |
| October 29, 2021 Filed Nov 3, 2021 01:50 UTC |
BOTHWELL IAN TDirector · Chief Financial Officer · 10% owner
|
OtherCommon Stock | 15,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-21-005202 · ownership.xml · nonDerivative · entry 2 BOTHWELL IAN T · CIK 0001207638 · Director · Chief Financial Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,018,726 F1 · kind: The shares of common stock of Organicell Regenerative Medicine, Inc., a Nevada corporation (the "Company") were disposed of and acquired, respectively, pursuant to an Exchange Agreement dated October 29, 2021 (the "Agreement"), whereby the Reporting Person exchanged shares of common stock of the Company previously issued under the Organicell Regenerative Medicine, Inc. Management and Consultants Performance Stock Plan for shares of common stock of the Company in the Organicell Regenerative Medicine, Inc. 2021 Equity Incentive Plan. The newly issued shares shall vest on December 31, 2023. F2 · price: Received in exchange for the Company's common stock on a 1:1 basis. This exchange was completed in connection with the Agreement. Read SEC document |
| October 29, 2021 Filed Nov 3, 2021 01:50 UTC |
BOTHWELL IAN TDirector · Chief Financial Officer · 10% owner
|
OtherCommon Stock | 15,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-21-005202 · ownership.xml · nonDerivative · entry 1 BOTHWELL IAN T · CIK 0001207638 · Director · Chief Financial Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,018,726 F1 · kind: The shares of common stock of Organicell Regenerative Medicine, Inc., a Nevada corporation (the "Company") were disposed of and acquired, respectively, pursuant to an Exchange Agreement dated October 29, 2021 (the "Agreement"), whereby the Reporting Person exchanged shares of common stock of the Company previously issued under the Organicell Regenerative Medicine, Inc. Management and Consultants Performance Stock Plan for shares of common stock of the Company in the Organicell Regenerative Medicine, Inc. 2021 Equity Incentive Plan. The newly issued shares shall vest on December 31, 2023. F2 · price: Received in exchange for the Company's common stock on a 1:1 basis. This exchange was completed in connection with the Agreement. Read SEC document |
| October 29, 2021 Filed Nov 3, 2021 01:52 UTC |
Mitrani AlbertDirector · Chief Executive Officer · 10% owner
|
OtherCommon Stock | 15,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-21-005205 · ownership.xml · nonDerivative · entry 2 Mitrani Albert · CIK 0001644416 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,790,190 F1 · kind: The shares of common stock of Organicell Regenerative Medicine, Inc., a Nevada corporation (the "Company") were disposed of and acquired, respectively, pursuant to an Exchange Agreement dated October 29, 2021 (the "Agreement"), whereby the Reporting Person exchanged shares of common stock of the Company previously issued under the Organicell Regenerative Medicine, Inc. Management and Consultants Performance Stock Plan for shares of common stock of the Company in the Organicell Regenerative Medicine, Inc. 2021 Equity Incentive Plan. The newly issued shares shall vest on December 31, 2023. F2 · price: Received in exchange for the Company's common stock on a 1:1 basis. This exchange was completed in connection with the Agreement. Read SEC document |
| October 29, 2021 Filed Nov 3, 2021 01:52 UTC |
Mitrani AlbertDirector · Chief Executive Officer · 10% owner
|
OtherCommon Stock | 15,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-21-005205 · ownership.xml · nonDerivative · entry 1 Mitrani Albert · CIK 0001644416 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,790,190 F1 · kind: The shares of common stock of Organicell Regenerative Medicine, Inc., a Nevada corporation (the "Company") were disposed of and acquired, respectively, pursuant to an Exchange Agreement dated October 29, 2021 (the "Agreement"), whereby the Reporting Person exchanged shares of common stock of the Company previously issued under the Organicell Regenerative Medicine, Inc. Management and Consultants Performance Stock Plan for shares of common stock of the Company in the Organicell Regenerative Medicine, Inc. 2021 Equity Incentive Plan. The newly issued shares shall vest on December 31, 2023. F2 · price: Received in exchange for the Company's common stock on a 1:1 basis. This exchange was completed in connection with the Agreement. Read SEC document |
| October 29, 2021 Filed Nov 3, 2021 01:51 UTC |
Shapiro George CraigDirector · Chief Medical Officer
|
OtherCommon Stock | 5,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-21-005203 · ownership.xml · nonDerivative · entry 2 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,604,187 F1 · kind: The shares of common stock of Organicell Regenerative Medicine, Inc., a Nevada corporation (the "Company") were disposed of and acquired, respectively, pursuant to an Exchange Agreement dated October 29, 2021 (the "Agreement"), whereby the Reporting Person exchanged shares of common stock of the Company previously issued under (i) the Organicell Regenerative Medicine, Inc. Management and Consultants Performance Stock Plan and (4,500,000 shares) (ii) the contractual arrangement of the Reporting Person with the Company (500,000 shares) for shares of common stock of the Company in the Organicell Regenerative Medicine, Inc. 2021 Equity Incentive Plan. The newly issued shares shall vest on December 31, 2023. F2 · price: Received in exchange for the Company's common stock on a 1:1 basis. This exchange was completed in connection with the Agreement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.